The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System — Lake Success, New York

The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System is a clinical research site located in Lake Success, New York, United States 11042.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System has participated in 1 clinical trials.

Therapeutic areas: Interstitial Cystitis, Bladder Pain Syndrome.

Sponsors: Urigen.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System?

The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System conducted?

The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System has 1 clinical trials on record. Their work covers Interstitial Cystitis, Bladder Pain Syndrome.

Is The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System accredited by Crixeo Health?

The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.